For the second time since it opened in 2023, Arkansas' only proton therapy center has issued a notice to creditors of its ...

Some of Colorado’s spending woes in Medicaid can be traced to lawmakers who had approved new or expanded programs in the last ...

In 2026, digital wellness has shifted from supplements and wearables to sound-based programs promising mental clarity ...

Antivirals given for chronic hepatitis B include nucleos(t)ide analog monotherapy and pegylated interferon-alpha therapy, but ...

The state’s Medicaid program — which covers about one in four Coloradans — is poised for its largest single-year jump in at least two decades, with officials proposing a $2.3 billion increase, even as ...

She definitely deserved to be fired. She helped Trump turn the Department of Justice into an instrument of partisan vengeance ...

Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Mesoblast offers asymmetric risk-reward with Ryoncil's rapid pediatric SR-aGvHD launch and multiple late-stage pipeline catalysts. Learn why MESO stock is a hold.

If you're feeling anxious about current political events or the state of public affairs, rest assured, you're not alone. Many people report feeling stressed about political ...

Renault Shirley remembers the first time he was asked to falsify billing reports for Kentucky’s largest drug rehab center.

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript March 31, 2026 Operator: Good morning, ladies and ...

Prestigious Publication Reinforces risto-cel’s Durable, Differentiated Clinical Data for the Treatment of SCD with Severe ...